| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 235.08B | 238.93B | 180.84B | 245.72B | 245.43B |
| Gross Profit | 96.81B | 101.74B | 68.00B | 93.97B | 100.36B |
| EBITDA | 55.98B | 64.85B | 42.03B | 67.28B | 80.61B |
| Net Income | 30.10B | 36.00B | 22.37B | 40.30B | 51.34B |
Balance Sheet | |||||
| Total Assets | 359.66B | 341.51B | 375.43B | 373.54B | 356.53B |
| Cash, Cash Equivalents and Short-Term Investments | 56.54B | 44.76B | 92.62B | 106.05B | 108.40B |
| Total Debt | 49.87B | 60.18B | 93.02B | 99.21B | 123.19B |
| Total Liabilities | 140.39B | 145.34B | 188.04B | 212.66B | 237.01B |
| Stockholders Equity | 219.27B | 196.17B | 187.39B | 160.88B | 119.52B |
Cash Flow | |||||
| Free Cash Flow | 35.06B | 12.99B | -8.59B | 23.18B | 70.51B |
| Operating Cash Flow | 48.80B | 38.48B | 2.94B | 29.99B | 73.61B |
| Investing Cash Flow | -16.95B | -27.71B | -11.95B | -7.83B | -3.35B |
| Financing Cash Flow | -21.51B | -58.11B | -6.31B | -25.11B | -3.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥2.06T | 22.85 | 21.73% | 2.29% | -3.12% | -4.90% | |
82 Outperform | ¥3.62T | 40.51 | 53.12% | 1.11% | 12.01% | 26.66% | |
80 Outperform | ¥7.20T | 52.09 | 25.78% | 0.79% | 11.08% | 9.32% | |
79 Outperform | ¥23.78T | 41.72 | 26.01% | 1.79% | 0.49% | 6.10% | |
78 Outperform | ¥18.37T | 50.66 | 47.37% | 0.25% | 44.75% | 135.64% | |
67 Neutral | ¥1.93T | 63.71 | ― | 0.73% | -1.61% | -16.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |